Eli Lilly became the second drugmaker this week to sue the U.S. government for rejecting their proposed changes to a program ...

The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain ...

Wolfe projects a positive outlook for Pharma & Large-Cap Biotech stocks despite potential policy changes as part of Make America Healthy Again movement. Read more here.

Medtech shouldn’t be greatly impacted if vaccine critic Robert F. Kennedy Jr. is appointed as head of HHS, according to a ...